Hot Stock for Investors: Endo International plc (ENDP)

Lloyd Doyle
October 19, 2017

Insider Trades for Endo International plc show that the latest trade was made on 30 Sep 2017 where Pera Antonio R, the Officer completed a transaction type "Sell" in which 135 shares were traded at a price of $8.48.

Endo International plc - Ordina (NASDAQ:ENDP). The firm is expected to report its next quarterly earnings results on Tuesday, November 14th.

Hexavest Inc. bought 2,243 shares in the previous quarter increasing its stake in Endo International plc - Ordina (ENDP) by 0.2%. The firm had revenue of $875.73 million for the quarter, compared to analysts' expectations of $832.66 million.

The company's quick ratio for most recent quarter is 0.8 along with current ratio for most recent quarter of 1. The company's revenue for the quarter was down 4.9% on a year-over-year basis. Deutsche Bank AG decreased their price objective on shares of Endo International PLC from $18.00 to $15.00 and set a "buy" rating for the company in a report on Friday, July 7th. The company rocked its 52-Week High of $21.87 and touched its 52-Week Low of $7.4. Zacks Investment Research upgraded Endo International PLC from a hold rating to a buy rating and set a $9.75 price target on the stock in a research report on Wednesday, October 11th. Through this figure traders can analyze that ENDP show whether or not a stock now most active and standing in buying side or sell side. The company's Relative Strength Index which shows price strength now stands at 38.03. Endo Int'l Plc (NASDAQ:ENDP)'s price to free cash flow for trailing twelve months is 6.33. Currently, the stock is -23.16% from its 50-Day High and 1.76% from the 50-day low. Shares are trading at $7.62 quite a bit lower than $8.67, the stock's 50 day moving average and which is quite a bit lower than the 200 day moving average of $10.54. The share price was last seen 0.26% higher, reaching at $7.64 on 10/17/2017. Following the completion of the transaction, the chief financial officer now directly owns 13,729 shares in the company, valued at $108,321.81. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Following stock price levels as a percentage of the 52 week high/low range, we can see that shares of SouFun Holdings Limited (NYSE:SFUN) have a value of 96.72. Ensco plc's beta is 1.89 whilst the stock has an average true range (ATR) of 0.28.

In other Endo International PLC news, CFO Blaise Coleman purchased 6,500 shares of the company's stock in a transaction on Tuesday, August 15th. The stock price hovered in an intraday range of $5.55- $5.74. Bank of New York Mellon Corp lifted its holdings in Endo International PLC by 38.7% in the first quarter. IL bought a new position in Endo International PLC in the second quarter worth about $126,000.

Acadian Asset Management LLC downsized its holdings by shedding 1,118,374 shares a decrease of 100.0% from 06/30/2017 to 09/30/2017. TIAA CREF Investment Management LLC now owns 649,535 shares of the company's stock valued at $7,255,000 after acquiring an additional 10,387 shares during the period. Point View Wealth Management Inc. lifted its holdings in Endo International PLC by 16.6% in the second quarter. Given that liquidity is king in short-term, SCYX is a stock with 27.68 million shares outstanding that normally trades 7.26% of its float. Hedge funds and other institutional investors own 90.74% of the company's stock. The Company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel for pain, urology, endocrinology, and oncology.

Other reports by Iphone Fresh

Discuss This Article